# drexml: A command line tool and Python package for drug repurposing

**Authors:** Marina Esteban-Medina, Víctor Manuel de la Oliva Roque, Sara Herráiz-Gil, María Peña-Chilet, Joaquín Dopazo, Carlos Loucera

PMC · DOI: 10.1016/j.csbj.2024.02.027 · Computational and Structural Biotechnology Journal · 2024-03-01

## TL;DR

drexml is a tool that uses machine learning and modeling to find new drug uses for diseases, validated in two rare diseases.

## Contribution

drexml introduces a novel drug repurposing framework combining machine learning and mechanistic modeling with explainability tools.

## Key findings

- In Fanconi Anemia, drexml successfully predicted already validated repurposed drugs.
- For Familial Melanoma, drexml identified a set of promising drugs for further investigation.

## Abstract

We introduce drexml, a command line tool and Python package for rational data-driven drug repurposing. The package employs machine learning and mechanistic signal transduction modeling to identify drug targets capable of regulating a particular disease. In addition, it employs explainability tools to contextualize potential drug targets within the functional landscape of the disease. The methodology is validated in Fanconi Anemia and Familial Melanoma, two distinct rare diseases where there is a pressing need for solutions. In the Fanconi Anemia case, the model successfully predicts previously validated repurposed drugs, while in the Familial Melanoma case, it identifies a promising set of drugs for further investigation.

## Linked entities

- **Diseases:** Fanconi Anemia (MONDO:0019391), Familial Melanoma (MONDO:0018961)

## Full-text entities

- **Diseases:** Fanconi Anemia (MESH:D005199), Familial Melanoma (OMIM:155600)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10950807/full.md

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10950807/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC10950807/full.md

---
Source: https://tomesphere.com/paper/PMC10950807